Alzamend Neuro, Inc.’s Q2 2027 10-Q window runs Dec 7, 2026 to Dec 15, 2026.
Based on 8 prior 10-Q filings.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR